1. Home
  2. SWKH vs RPID Comparison

SWKH vs RPID Comparison

Compare SWKH & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SWK Holdings Corporation

SWKH

SWK Holdings Corporation

HOLD

Current Price

$15.90

Market Cap

198.4M

Sector

Finance

ML Signal

HOLD

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$1.76

Market Cap

204.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWKH
RPID
Founded
1996
2006
Country
United States
United States
Employees
9
N/A
Industry
Diversified Financial Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.4M
204.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SWKH
RPID
Price
$15.90
$1.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$18.00
$8.00
AVG Volume (30 Days)
104.8K
154.2K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.78
EPS
N/A
N/A
Revenue
N/A
$33,587,000.00
Revenue This Year
N/A
$19.12
Revenue Next Year
N/A
$18.42
P/E Ratio
$9.18
N/A
Revenue Growth
N/A
19.74
52 Week Low
$13.91
$1.81
52 Week High
$17.90
$4.94

Technical Indicators

Market Signals
Indicator
SWKH
RPID
Relative Strength Index (RSI) 32.19 30.64
Support Level $14.69 N/A
Resistance Level $17.08 $2.46
Average True Range (ATR) 0.37 0.13
MACD -0.05 -0.01
Stochastic Oscillator 12.06 3.66

Price Performance

Historical Comparison
SWKH
RPID

About SWKH SWK Holdings Corporation

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Share on Social Networks: